Literature DB >> 15111691

Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.

G M Fabrizi1, T Cavallaro, C Angiari, L Bertolasi, I Cabrini, M Ferrarini, N Rizzuto.   

Abstract

The axonal type 2 Charcot-Marie-Tooth disease (CMT2) is phenotypically poorly characterized. Here the authors report a family with a Pro22Ser mutation in the neurofilament-light gene (NF-L; CMT2E) manifesting electrophysiologically as the demyelinating type 1 CMT (CMT1) and pathologically as an axonopathy with giant axons and accumulation of disorganized NF. NF-L should be investigated in CMT2 as well as in CMT1 not associated with the usual genes PMP22, Cx32, and P0.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111691     DOI: 10.1212/01.wnl.0000120664.07186.3c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Axonal and periaxonal swelling precede peripheral neurodegeneration in KCC3 knockout mice.

Authors:  Nellie Byun; Eric Delpire
Journal:  Neurobiol Dis       Date:  2007-06-23       Impact factor: 5.996

Review 2.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome.

Authors:  Xiang Zhu; Eun-Sook Cho; Quan Sha; Jianbin Peng; Yelena Oksov; Siok Yuen Kam; Mengfatt Ho; Ruth H Walker; Soohee Lee
Journal:  Am J Pathol       Date:  2014-01-07       Impact factor: 4.307

5.  Ubiquitin ligase defect by DCAF8 mutation causes HMSN2 with giant axons.

Authors:  Christopher J Klein; Yanhong Wu; Peter Vogel; Hans H Goebel; Carsten Bönnemann; Kristen Zukosky; Maria-Victoria Botuyan; Xiaohui Duan; Sumit Middha; Elizabeth J Atkinson; Georges Mer; Peter J Dyck
Journal:  Neurology       Date:  2014-02-05       Impact factor: 9.910

6.  Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings.

Authors:  Pankaj B Agrawal; Mugdha Joshi; Nicholas S Marinakis; Klaus Schmitz-Abe; Pedro D S C Ciarlini; Jane C Sargent; Kyriacos Markianos; Umberto De Girolami; David A Chad; Alan H Beggs
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

Review 7.  Neuropathology of Charcot-Marie-Tooth and related disorders.

Authors:  J Michael Schröder
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 8.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 9.  Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth disease.

Authors:  Stephan Züchner; Jeffery M Vance
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

10.  Charcot-marie-tooth disease: seventeen causative genes.

Authors:  Jung-Hwa Lee; Byung-Ok Choi
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.